APLT Insider Trading Activity and SEC Form 4 Filings
APLT insider trading summary
Over the past 12 months, insiders at Applied Therapeutics, Inc. (APLT) reported 1 sale worth $5K by 1 insider and no open-market purchases on SEC Form 4. Net insider selling was $5K.
Latest APLT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 16, 2025 | Stacy J. Kanter | Insider | Sell | $5K (43,000 @ $0.11) |
| Mar 4, 2025 | Riccardo Perfetti | Chief Medical Officer | Sell | $5K (10,366 @ $0.44) |
| Mar 4, 2025 | Leslie D. Funtleyder | See Remarks | Sell | $6K (14,502 @ $0.44) |
| Mar 4, 2025 | Constantine Chinoporos | See Remarks | Sell | $197 (447 @ $0.44) |
| Feb 6, 2025 | Constantine Chinoporos | See Remarks | Sell | $17K (28,117 @ $0.61) |
| Feb 6, 2025 | Leslie D. Funtleyder | See Remarks | Sell | $14K (22,950 @ $0.61) |
| Feb 6, 2025 | Riccardo Perfetti | Chief Medical Officer | Sell | $53K (86,078 @ $0.61) |
| Aug 22, 2024 | Leslie D. Funtleyder | Chief Financial Officer | Sell | $79K (13,530 @ $5.83) |
| Aug 22, 2024 | Riccardo Perfetti | Chief Medical Officer | Sell | $132K (22,681 @ $5.83) |
| Aug 14, 2024 | Shoshana Shendelman | President and CEO | Sell | $709K (119,591 @ $5.93) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.